ES8604511A1 - Un procedimiento para la preparacion de derivados de -lactama - Google Patents

Un procedimiento para la preparacion de derivados de -lactama

Info

Publication number
ES8604511A1
ES8604511A1 ES527711A ES527711A ES8604511A1 ES 8604511 A1 ES8604511 A1 ES 8604511A1 ES 527711 A ES527711 A ES 527711A ES 527711 A ES527711 A ES 527711A ES 8604511 A1 ES8604511 A1 ES 8604511A1
Authority
ES
Spain
Prior art keywords
substd
heterocyclyl
aryl
opt
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES527711A
Other languages
English (en)
Other versions
ES527711A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES527711A0 publication Critical patent/ES527711A0/es
Publication of ES8604511A1 publication Critical patent/ES8604511A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C07D231/26—1-Phenyl-3-methyl-5- pyrazolones, unsubstituted or substituted on the phenyl ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE B-LACTAMA. CONSISTE EN SOMETER A REACCION DE FORMILACION UN COMPUESTO DE FORMULA (II) A UNA TEMPERATURA COMPRENDIDA ENTRE C50JC Y 30JC EN UN DISOLVENTE APROTICO EN PRESENCIA DE UNA BASE TERCIARIA, PARA OBTENER DERIVADOS DE B-LACTAMA DE FORMULA (I) DONDE R1 ES FENILO, FENILO SUSTITUIDO O UN ANILLO HETEROCICLICO DE 5 O 6 MIEMBROS QUE CONTIENE HASTA TRES HETEROATOMOS SELECCIONADOS ENTRE OXIGENO, AZUFRE O NITROGENO, OPCIONALMENTE SUSTITUIDO CON HIDROXI, AMINO, HALOGENO O ALCOXI C 1 A 6; X REPRESENTA UN COMPUESTO DE FORMULA (III); E Y ES UN COMPUESTO DE FORMULA (IV). TIENEN APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD ANTIBACTERIANA.
ES527711A 1982-03-31 1983-12-01 Un procedimiento para la preparacion de derivados de -lactama Expired ES8604511A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8209426 1982-03-31

Publications (2)

Publication Number Publication Date
ES527711A0 ES527711A0 (es) 1986-02-01
ES8604511A1 true ES8604511A1 (es) 1986-02-01

Family

ID=10529420

Family Applications (2)

Application Number Title Priority Date Filing Date
ES521192A Expired ES8405411A1 (es) 1982-03-31 1983-03-30 Un procedimiento para la preparacion de derivados de b-lactama.
ES527711A Expired ES8604511A1 (es) 1982-03-31 1983-12-01 Un procedimiento para la preparacion de derivados de -lactama

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES521192A Expired ES8405411A1 (es) 1982-03-31 1983-03-30 Un procedimiento para la preparacion de derivados de b-lactama.

Country Status (7)

Country Link
US (1) US4537886A (es)
EP (1) EP0090656A1 (es)
JP (1) JPS58183692A (es)
AU (1) AU1294383A (es)
ES (2) ES8405411A1 (es)
NZ (1) NZ203734A (es)
ZA (1) ZA832226B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8409986D0 (en) * 1984-04-17 1984-05-31 Beecham Group Plc Beta-lactam antibacterial agents
DE3508258A1 (de) * 1985-03-08 1986-09-18 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zur herstellung und ihre verwendung als und in arzneimitteln
DE3509618A1 (de) * 1985-03-16 1986-09-18 Bayer Ag, 5090 Leverkusen Ss-lactam-antibiotika, verfahren zur herstellung und ihre verwendung als arzneimittel
US4870168A (en) * 1987-02-26 1989-09-26 Bristol-Myers Company 3-Unsaturated alkyl cephems from 3-triflyl cephems
DE3803169A1 (de) * 1988-02-03 1989-08-17 Bayer Ag Ss-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln
US5128336A (en) * 1988-03-23 1992-07-07 Eli Lilly And Company 3-(substituted)-1-carba(dethia)-3-cephems
US20050245498A1 (en) * 2002-05-14 2005-11-03 Shoichet Brian K Sterically-awkward beta-lactamase inhibitors
US20080146535A1 (en) * 2003-04-30 2008-06-19 Tomasz Glinka Compositions comprising carbacephem beta-lactam antibiotics and beta-lactamase inhibitors
EA201070504A1 (ru) * 2007-10-25 2010-12-30 Эйкеоджен, Инк. КАРБАЦЕФЕМ β-ЛАКТАМОВЫЕ АНТИБИОТИКИ
WO2010030810A1 (en) * 2008-09-10 2010-03-18 Achaogen, Inc. Carbacephem beta-lactam antibiotics
JP7184646B2 (ja) 2015-12-15 2022-12-06 メルク・シャープ・アンド・ドーム・エルエルシー ビアリールモノバクタム化合物および細菌感染治療のためのそれの使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH10309A (en) * 1973-10-19 1976-11-17 Yamanouchi Pharma Co Ltd Penicillin derivatives
JPS5195090A (en) * 1975-02-14 1976-08-20 66 * dd22 * 33 hidorokishipiridajin 44 karubokishiamido * 22 * paraahidorokishifueniru * asetoamido * penishiransanno seiho
DE2720579A1 (de) * 1977-05-07 1978-11-09 Bayer Ag Beta-lactam-verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2810083A1 (de) * 1978-03-08 1979-09-20 Bayer Ag Beta-lactam-verbindungen
JPS5616489A (en) * 1979-07-20 1981-02-17 Ajinomoto Co Inc Imidazolecarboxylic acid derivative

Also Published As

Publication number Publication date
NZ203734A (en) 1986-03-14
US4537886A (en) 1985-08-27
EP0090656A1 (en) 1983-10-05
ES527711A0 (es) 1986-02-01
ES521192A0 (es) 1984-06-01
JPS58183692A (ja) 1983-10-26
ZA832226B (en) 1984-02-29
AU1294383A (en) 1983-10-06
ES8405411A1 (es) 1984-06-01

Similar Documents

Publication Publication Date Title
ES8604511A1 (es) Un procedimiento para la preparacion de derivados de -lactama
JPS5630964A (en) Novel substituted quinolinecarboxylic acid and its preparation
DE3168572D1 (en) Cephalosporin derivatives, process for their preparation and antibiotic compositions containing them
GB1004670A (en) Penicillins
ES476856A1 (es) Procedimiento para la obtencion de derivados de acidos aza- biciclo-3,2-0 carboxilicos.
ES8301237A1 (es) Un procedimiento para la preparacion de un derivado 2-tiope-nem
DE3854288D1 (de) Cephalosporinderivate und Verfahren zur Herstellung von Cephem-Verbindungen.
ES471770A1 (es) Procedimiento para la obtencion de compuestos de b-lactama
NO810758L (no) Fremgangsmaate for oekning av den orale absorpsjon av beta-lactamantibiotika
ES8103094A1 (es) Un procedimiento para la preparacion de 1,1-dioxido de acidopenicilanico y esteres del mismo
ES471964A1 (es) Un procedimiento para la preparacion de un tiofeno
ES442217A1 (es) Procedimiento para la obtencion de derivados cefem.
GB1067965A (en) Penicillins, esters, amides and salts thereof
GB1293590A (en) New penicillanic acid derivatives
EP0354757A3 (en) Cephalosporins and homologous compounds, process for their preparation and pharmaceutical compositions containing them
AU616453B2 (en) Beta-lactam antibiotics, processes for their preparation and their use as and in medicaments
FR2610630B2 (fr) Nouveaux derives de l'acide 1-dethia 2-thia cephalosporanique, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
US3987032A (en) Penicillins
GB1057028A (en) New penicillins
SE7501155L (es)
ES8603488A1 (es) Un procedimiento para la preparacion de un compuesto.
JPS54126735A (en) Bactericidal composition for medical use
FR2388814A1 (fr) Nouveaux derives de l'acide clavulanique, utilisables comme medicament
PH22795A (en) 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives, pharmaceutical composition containing said compound and method of use thereof
GB1053415A (es)